132 related articles for article (PubMed ID: 2242412)
1. Efficient design for estimation of median lethal dose and quantal dose-response curves.
Kalish LA
Biometrics; 1990 Sep; 46(3):737-48. PubMed ID: 2242412
[TBL] [Abstract][Full Text] [Related]
2. Kernel estimates of dose response.
Staniswalis JG; Cooper V
Biometrics; 1988 Dec; 44(4):1103-19. PubMed ID: 3233249
[TBL] [Abstract][Full Text] [Related]
3. Interval estimation of the LD50 based on an up-and-down experiment.
Choi SC
Biometrics; 1990 Jun; 46(2):485-92. PubMed ID: 2364133
[TBL] [Abstract][Full Text] [Related]
4. Interval estimation of the median lethal dose.
Williams DA
Biometrics; 1986 Sep; 42(3):641-5. PubMed ID: 3567296
[TBL] [Abstract][Full Text] [Related]
5. Adaptive urn designs for estimating several percentiles of a dose--response curve.
Mugno R; Zhus W; Rosenberger WF
Stat Med; 2004 Jul; 23(13):2137-50. PubMed ID: 15211608
[TBL] [Abstract][Full Text] [Related]
6. Choice of number of doses for maximum likelihood estimation of the ED50 for quantal dose-response data.
Müller HG; Schmitt T
Biometrics; 1990 Mar; 46(1):117-29. PubMed ID: 2350566
[TBL] [Abstract][Full Text] [Related]
7. Retrospective analysis of sequential dose-finding designs.
O'Quigley J
Biometrics; 2005 Sep; 61(3):749-56. PubMed ID: 16135026
[TBL] [Abstract][Full Text] [Related]
8. Dose-time-response cumulative multinomial generalized linear model.
Chen DG
J Biopharm Stat; 2007; 17(1):173-85. PubMed ID: 17219762
[TBL] [Abstract][Full Text] [Related]
9. A measure of tumorigenic potency incorporating dose-response shape.
Meier KL; Bailer AJ; Portier CJ
Biometrics; 1993 Sep; 49(3):917-26. PubMed ID: 8241378
[TBL] [Abstract][Full Text] [Related]
10. An unbalanced experimental design for dose response studies.
Farmer JH; Uhler RJ; Haley TJ
J Environ Pathol Toxicol; 1977; 1(2):293-9. PubMed ID: 553136
[TBL] [Abstract][Full Text] [Related]
11. Bootstrap estimation of benchmark doses and confidence limits with clustered quantal data.
Zhu Y; Wang T; Jelsovsky JZ
Risk Anal; 2007 Apr; 27(2):447-65. PubMed ID: 17511711
[TBL] [Abstract][Full Text] [Related]
12. A sequential design to estimate sensitivity and specificity of a diagnostic or screening test.
Wruck LM; Yiannoutsos CT; Hughes MD
Stat Med; 2006 Oct; 25(20):3458-73. PubMed ID: 16374904
[TBL] [Abstract][Full Text] [Related]
13. Bayesian design for dose-response curves with penalized risk.
Sun D; Tsutakawa RK
Biometrics; 1997 Dec; 53(4):1262-73. PubMed ID: 9423248
[TBL] [Abstract][Full Text] [Related]
14. Simple designs and model-free tests for synergy.
Laska EM; Meisner M; Siegel C
Biometrics; 1994 Sep; 50(3):834-41. PubMed ID: 7981403
[TBL] [Abstract][Full Text] [Related]
15. Estimation of quantal dose response of drugs by the Spearman-Karber method: a computer program written in BASIC.
Fung KP; Wong TW
J Singapore Paediatr Soc; 1989; 31(3-4):129-32. PubMed ID: 2638718
[TBL] [Abstract][Full Text] [Related]
16. Interval estimation of inverse dose-response.
Alho JM; Valtonen E
Biometrics; 1995 Jun; 51(2):491-501. PubMed ID: 7662838
[TBL] [Abstract][Full Text] [Related]
17. Monotone smoothing with application to dose-response curves and the assessment of synergism.
Kelly C; Rice J
Biometrics; 1990 Dec; 46(4):1071-85. PubMed ID: 2085626
[TBL] [Abstract][Full Text] [Related]
18. Estimation of a parameter and its exact confidence interval following sequential sample size reestimation trials.
Cheng Y; Shen Y
Biometrics; 2004 Dec; 60(4):910-8. PubMed ID: 15606411
[TBL] [Abstract][Full Text] [Related]
19. Quantalization of continuous data for benchmark dose estimation.
Gaylor DW
Regul Toxicol Pharmacol; 1996 Dec; 24(3):246-50. PubMed ID: 8975754
[TBL] [Abstract][Full Text] [Related]
20. Three-dose-cohort designs in cancer phase I trials.
Huang B; Chappell R
Stat Med; 2008 May; 27(12):2070-93. PubMed ID: 17764082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
